Alcon Targets Faster Growth In 2026 With New Cataract Surgery Systems

Benzinga_recent_news01-31

William Blair initiated coverage on Alcon Inc. (NYSE:ALC) on Friday with a Market Perform rating. Over the past two years, Alcon has been aggressive in driving top-line growth both internally (...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2607081023?lang=en_US&edition=fundamental","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/01/30/Genetic-Research-And-Biotech-Science-Con.jpeg?optimize=medium&dpr=2&auto=webp&width=240","is_english":true,"pubTime":"2026-01-31 02:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2607081023","market":"sh","top_or_hot":-1,"title":"Alcon Targets Faster Growth In 2026 With New Cataract Surgery Systems","media":"Benzinga_recent_news","content":"<div>\n<p>William Blair initiated coverage on Alcon Inc. (NYSE:ALC) on Friday with a Market Perform rating.\nOver the past two years, Alcon has been aggressive in driving top-line growth both internally (...</p>\n\n<a href=\"https://www.benzinga.com/analyst-stock-ratings/initiation/26/01/50275776/alcon-targets-faster-growth-in-2026-with-new-cataract-surgery-systems\">Source Link</a>\n\n</div>\n","source":"benzinga_recent_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alcon Targets Faster Growth In 2026 With New Cataract Surgery Systems</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlcon Targets Faster Growth In 2026 With New Cataract Surgery Systems\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-01-31 02:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/analyst-stock-ratings/initiation/26/01/50275776/alcon-targets-faster-growth-in-2026-with-new-cataract-surgery-systems><strong>Benzinga_recent_news</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>William Blair initiated coverage on Alcon Inc. (NYSE:ALC) on Friday with a Market Perform rating.\nOver the past two years, Alcon has been aggressive in driving top-line growth both internally (...</p>\n\n<a href=\"https://www.benzinga.com/analyst-stock-ratings/initiation/26/01/50275776/alcon-targets-faster-growth-in-2026-with-new-cataract-surgery-systems\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4198","symbol_name":"医疗保健用品","start_time":0,"source_url":"https://www.benzinga.com/analyst-stock-ratings/initiation/26/01/50275776/alcon-targets-faster-growth-in-2026-with-new-cataract-surgery-systems","article_id":"2607081023","we_media_id":null,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/01/30/Genetic-Research-And-Biotech-Science-Con.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/analyst-stock-ratings/initiation/26/01/50275776/alcon-targets-faster-growth-in-2026-with-new-cataract-surgery-systems","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2607081023","pubTimestamp":1769796000,"columns":[],"sourceInfo":{"source_id":"benzinga_recent_news","name":"Benzinga"},"weMediaInfo":null,"summary":"William Blair initiates Alcon with a Market Perform rating, citing strong pipeline, UNITY platform launches, and rising consumables growth, while noting the stock already trades at a premium.","collect":0,"end_time":0,"defaultTopTitle":"benzinga.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4198":"医疗保健用品","ALC":"Alcon Inc","LU1804176565.USD":"EASTSPRING INV GLOBAL GROWTH EQUITY \"A\" (USD) ACC","LU2265009873.SGD":"Eastspring Investments - Global Growth Equity AS SGD-H","BK4534":"瑞士信贷持仓"},"translate_title":"爱尔康的目标是通过新型白内障手术系统在2026年实现更快增长","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ALC":1},"content_text":"William Blair initiated coverage on Alcon Inc. (NYSE:ALC) on Friday with a Market Perform rating.\nOver the past two years, Alcon has been aggressive in driving top-line growth both internally (increased R&D spend) and externally (several announced tuck-in acquisitions).\nAnalyst Steven Lichtman wrote that the premium is warranted given the company's full pipeline, but with the stock already trading at a roughly 25% premium (slightly above historical) based on a 2026 P/E multiple, the analyst looks for potential upside drivers to estimates, including mix upgrade potential in consumables and performance of Alcon's dry eye disease drug, Tryptyr.\nAlcon's equipment segment was about 10% of the company’s sales. The biggest opportunity for Alcon in equipment is the launch of its UNITY platform for cataract and vitreoretinal procedures: UNITY VCS (launched 2025) and UNITY CS (launching 2026) surgical platforms.\nAlcon has about 30,000 legacy systems in the field; the majority are over 7 to 8 years old, approaching the typical replacement age of 10 years.\nFollowing a low-single-digit decline in equipment in the first half of 2025 as customers awaited the UNITY launches, growth accelerated meaningfully in the third quarter to 13% as pent-up demand began to be met.\nWilliam Blair expects further year-over-year growth acceleration in the fourth quarter of 2025 and the first half of 2026, targeting mid- to high teens on rollouts and with easy comparables over the next couple of quarters.\nAnalyst also adds that Alcon could see higher consumables usage and improved pricing across both systems and consumables as clinics gain more procedure capacity and lower total equipment costs with VCS.\nConsumables, which account for nearly 30% of sales, are expected to accelerate to about 7% constant-currency growth in 2026, up from 5% in 2025, driven by pull-through from premium-priced UNITY consumables.\nPrice Action: ALC stock is down 0.01% at $81.14 at the last check on Friday, according to Benzinga Pro data.\nPhoto: jittawit21/Shutterstock","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2607081023","isCrawlerRequest":true}